X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.fiercepharma.com/manufacturing/endos-par-pharma-issues-recall-blood-pressure-med-due-possible-contamination
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-3-2024-41763.pdf
https://www.fiercepharma.com/pharma/fda-cleared-approve-liquidias-inhaled-pah-drug-rival-uniteds-tyvaso
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/par-pharmaceutical-issues-voluntary-nationwide-recall-one-lot-treprostinil-injection-due-potential
https://www.prnewswire.com/news-releases/par-pharmaceutical-issues-voluntary-nationwide-recall-of-one-lot-of-treprostinil-injection-due-to-potential-for-silicone-particulates-in-the-product-solution-302087106.html
https://www.reuters.com/business/healthcare-pharmaceuticals/united-therapeutics-starts-litigation-with-fda-allowing-liquidias-drug-2024-02-21/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208906
https://www.globenewswire.com/news-release/2022/12/05/2567822/0/en/Liquidia-Announces-Collaboration-to-Develop-a-New-Infusion-Pump-for-Subcutaneous-Delivery-of-Treprostinil-Injection-to-Treat-Pulmonary-Arterial-Hypertension-PAH.html
https://endpts.com/long-after-first-nod-for-inhaled-tyvaso-united-therapeutics-scraps-phiii-in-ph-with-copd/
https://www.fiercepharma.com/pharma/lung-safety-review-delays-fda-decision-uniteds-tyvaso-dpi
https://www.ferrer.com/en/Ferrer-announces-distribution-agreement-with-United-Therapeutics-for-treprostinil-inhalation-solution-for-pulmonary-hypertension-associated-with-interstitial-lung-disease
https://www.prnewswire.com/news-releases/united-therapeutics-provides-an-update-on-the-progress-of-the-tyvaso-dpi-new-drug-application-301401842.html
https://www.prnewswire.com/news-releases/united-therapeutics-presents-tyvaso-dpi-breeze-clinical-data-at-the-european-respiratory-society-international-congress-2021-301369762.html
https://www.prnewswire.com/news-releases/united-therapeutics-announces-the-lancet-respiratory-medicine-publication-of-post-hoc-analysis-of-fvc-change-from-the-tyvaso-increase-study-301322737.html
https://www.prnewswire.com/news-releases/united-therapeutics-announces-fda-acceptance-of-tyvaso-dpi-new-drug-application-for-priority-review-301313312.html
https://www.benzinga.com/general/biotech/21/03/20398499/liquidia-announces-generic-treprostinil-injection-will-be-available-for-subcutaneous-route-of-adm
https://endpts.com/united-axes-pah-program-trevyent-once-bought-for-cheap-in-acquisition-of-a-rival-after-fda-feedback/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211574
https://endpts.com/with-pipeline-setbacks-mounting-united-snares-priority-voucher-for-inhaled-formulation-of-pah-med-tyvaso/
https://www.prnewswire.com/news-releases/united-therapeutics-receives-fda-orphan-drug-designation-for-treprostinil-for-the-treatment-of-idiopathic-pulmonary-fibrosis-301189016.html
https://www.prnewswire.com/news-releases/lipocine-announces-tentative-approval-of-tlando-301188975.html
https://www.prnewswire.com/news-releases/united-therapeutics-receives-fda-orphan-drug-designation-for-treprostinil-for-the-treatment-of-idiopathic-pulmonary-fibrosis-301189016.html
https://www.prnewswire.com/news-releases/united-therapeutics-highlights-poster-presentations-from-the-recent-chest-2020-meeting-301157525.html
https://www.prnewswire.com/news-releases/united-therapeutics-to-present-new-tyvaso-clinical-and-treprostinil-real-world-data-at-chest-annual-meeting-2020-301152732.html
https://www.prnewswire.com/news-releases/united-therapeutics-to-present-new-tyvaso-clinical-and-treprostinil-real-world-data-at-chest-annual-meeting-2020-301152732.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211574
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211574
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/alembic-pharma-arm-gets-tentative-usfda-nod-for-drug-to-treat-pulmonary-arterial-hypertension/articleshow/77972436.cms
https://www.business-standard.com/article/news-cm/alembic-pharmaceuticals-receives-usfda-approval-for-treprostinil-injection-120090700379_1.html
https://www.globenewswire.com/news-release/2020/08/28/2085355/0/en/Liquidia-Announces-Notice-of-Allowance-for-U-S-Patent-Application-Covering-Methods-of-Treating-Pulmonary-Hypertension-with-Dry-Powder-Treprostinil.html
https://www.prnewswire.com/news-releases/united-therapeutics-announces-us-fda-filing-acceptance-of-supplemental-new-drug-application-for-tyvaso-for-pulmonary-hypertension-associated-with-interstitial-lung-disease-301112921.html
https://www.prnewswire.com/news-releases/united-therapeutics-announces-increase-data-presentation-at-an-american-thoracic-society-virtual-session-301078035.html
https://www.prnewswire.com/news-releases/united-therapeutics-corporation-files-lawsuit-against-liquidia-for-infringement-of-tyvaso-patents-301071145.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210214
https://www.prnewswire.com/news-releases/united-therapeutics-announces-additional-results-from-freedom-ev-study-showing-the-hemodynamic-and-risk-status-reduction-benefits-of-orenitram-treatment-in-patients-with-pulmonary-arterial-hypertension-301045819.html
https://www.globenewswire.com/news-release/2020/04/08/2013503/0/en/Liquidia-Announces-FDA-Acceptance-of-New-Drug-Application-for-LIQ861-treprostinil-Inhalation-Powder-for-the-Treatment-of-Pulmonary-Arterial-Hypertension.html
https://www.ema.europa.eu/en/documents/overview/trepulmix-epar-medicine-overview_en.pdf
https://www.prnewswire.com/news-releases/united-therapeutics-announces-fda-approval-of-updated-label-for-orenitram-reflecting-results-of-freedom-ev-study-300941636.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209382
https://www.biospace.com/article/releases/correvio-highlights-fda-acceptance-of-united-therapeutics-trevyent-new-drug-application/?s=95
https://www.fiercepharma.com/pharma-asia/foreign-drugmakers-under-threat-as-china-rolls-out-drug-list-to-boost-generic
https://www.biopharmadive.com/news/sandoz-takes-united-therapeutics-to-court-for-anticompetitive-behavior/553053/
https://endpts.com/united-kills-its-phiii-pah-drug-after-it-fails-tyvaso-combo-study/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209382
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-19-2018-1537361296.pdf
https://endpts.com/struggling-mannkind-sees-shares-rocket-up-on-105m-plus-alliance-with-united-on-inhaled-treprostinil/
Market Place
Share 
